Skip to main content

News

By Sophie Porter | 02:04 am | May 07, 2020
The web-based application supports the triage, monitoring and treatment of COVID-19 patients.
By Dave Muoio | 04:36 pm | May 06, 2020
The startup, which specializes in a range of at-home testing kits, so far only offers a COVID-19 testing product for point-of-care providers.
By Laura Lovett | 04:32 pm | May 06, 2020
GSR Ventures led the round with participation from sequoia Capital, Storm Ventures, NextGen Venture Partners and BIXINK Therapeutics. 
By Laura Lovett | 03:00 pm | May 06, 2020
This news means that the Australian company will be able to expand to the United States. 
By Dave Muoio | 01:45 pm | May 06, 2020
The Fitbit Heart Study is looking to enroll 200,000 to 250,000 device owners, and will support clinical evaluation and regulatory submissions of the company's PPG atrial fibrillation algorithm.
By Piers Ford | 02:25 am | May 06, 2020
The scale of healthcare misinformation is a source of frustration - Healthinote seeks to counter the threat with a verified and up-to-date information resource.
By Rachel McArthur | 02:13 am | May 06, 2020
The antibacterial and antiviral card consists of a special layered metal coating that prevents pathogens from living on its surface.
By MobiHealthNews | 05:27 pm | May 05, 2020
Also: WellSky and Qlik create a new COVID-19 heat map for home health providers; DarioHealth integrates with MediOrbis. 
By Dave Muoio | 04:28 pm | May 05, 2020
The continuous remote monitor can help prevent complications driven by experimental COVID-19 treatments such as hydroxychloroquine or chloroquine, according to the agency.
By Laura Lovett | 04:23 pm | May 05, 2020
The study enrolled 420,000, but many participants with suspected atrial fibrillation failed to follow up with a study doctor.